We will showcase our antibody protein characterization solution at PEGS Boston 2016, April 25 – 29, at Seaport World Trade Center in Boston, MA.
Here are the things we can help you with:
- Restores your hybridoma cell line
- Confirms your antibody product
- Accelerates biosimilar development
We invite you for a brief chat at our booth #139. You will see the quality of the reports we deliver and get insights on the benefits of a real de novo solution has to offer.
You can schedule a meeting with us by sending an email to support@rapidnovor.com.
If you are unable to attend the conference, book a free consultation with us and we will walk you through the perks you will receive from our offerings.
Newsletter for All Things Protein Sequencing
Breakthrough Bispecific Antibody R&D Techniques, Apr 20 11:00am EST.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics